DrugDashboards

Major Triple Antibiotic

Bacitracin Zinc, Neomycin, Polymyxin B Sulfat · NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [USP'U]/g; POLYMYXIN B SULFATE 5000 [USP'U]/g · Ointment · Topical · Major Pharmaceuticals

NDC 00904-8805-31 · 1 TUBE in 1 BOX / 28 g in 1 TUBE · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.0886 per gram over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1Apr 2025Sep 2026$0.0886
17 price points · per GMSource: CMS NADAC

Medicaid spend (2025)

$25,909
3,093 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for bacitracin zinc, neomycin, polymyxin b sulfat (other) in the next 90 days

price up 7% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M004
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Bacitracin Zinc, Neomycin, Polymyxin B Sulfat (Ointment)

LabelerStrengthFirst seenLast seen
Major PharmaceuticalsNEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [USP'U]/g; POLYMYXIN B SULFATE 5000 [USP'U]/gAug 26, 2026Sep 2, 2026
Major PharmaceuticalsNEOMYCIN SULFATE 400 [USP'U]/g; BACITRACIN ZINC 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/gJul 22, 2026Aug 19, 2026
Major PharmaceuticalsBACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/gJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Major Triple Antibiotic — NDC 00904-8805-31," retrieved September 3, 2026, https://drugdashboards.com/drug/00904880531.

Free to cite with attribution — see how the data is put together.